Red Mountain Medical Holdings, Inc. v. Brill, M.D.

CourtDistrict Court, S.D. New York
DecidedMarch 2, 2023
Docket1:20-cv-02652
StatusUnknown

This text of Red Mountain Medical Holdings, Inc. v. Brill, M.D. (Red Mountain Medical Holdings, Inc. v. Brill, M.D.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Red Mountain Medical Holdings, Inc. v. Brill, M.D., (S.D.N.Y. 2023).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

------------------------------X

RED MOUNTAIN MEDICAL HOLDINGS,

INC. f/k/a CDx DIAGNOSTICS,

INC., MEMORANDUM AND ORDER

Plaintiff, 20 Civ. 2652 (NRB)

- against –

JOEL V. BRILL M.D. and PREDICTIVE HEALTH, LLC,

Defendants.

------------------------------X NAOMI REICE BUCHWALD UNITED STATES DISTRICT JUDGE

This is the second opinion by this Court evaluating Red Mountain Medical Holdings, Inc.’s, f/k/a CDX Diagnostics (“Red Mountain” or “plaintiff”) allegations that Dr. Joel Brill (“Brill”, collectively with his consulting company Predictive Health, LLC “defendants”) sabotaged a potential financing with the private equity firm, Kohlberg Kravis Roberts & Co., L.P. (“KKR”). While Red Mountain’s First Amended Complaint contained numerous causes of action, the Court’s first opinion dismissed all except one. See Mem. & Order, Sept. 27, 2021 (“Mem. & Order”), ECF No. 37. Specifically, the Court dismissed the claims that Brill breached the conflict and confidentiality provisions of his contracts with KKR and Accelmed, another potential investor, because Red Mountain was not a party to the contract and not a -1- third-party beneficiary. See Mem. & Order, at 8, ECF No. 37. The Court also dismissed actual and constructive fraud claims that Brill falsely misrepresented his conflict to Accelmed and misrepresented to Accelmed and KKR that Red Mountain employed improper billing methods. Id. at 19-20. In addition, the Court dismissed the claims that Brill tortiously interfered with Red Mountain’s transactions with both KKR and Accelmed, because the

plaintiff failed to bring the claims within the statute of limitations. Id. at 38. And finally, the Court dismissed the claim for unfair competition that alleged that Brill misrepresented Red Mountain’s information to the advantage of Red Mountain’s competitors in order to deprive Red Mountain from obtaining acceptance by the standard practice guidelines. Id. at 43. At this stage, the only remaining claim is one of “actual fraud for Brill’s alleged misrepresentation about not having a conflict of interest with respect to the KKR deal.” Id. at 20. This claim centers on the allegation that Brill was conflicted at

the time of his work with KKR due to his relationship with two competitors of Red Mountain, NinePoint Medical, Inc. (“NinePoint”) and Mauna Kea Technologies (“Mauna Kea”), and that because of those relationships, Brill falsely told KKR that he was not conflicted with the intent to be hired by KKR and to sabotage the financing. -2- Red Mountain asserts that if it had known of Brill’s alleged conflict at the time, it would not have allowed Brill to participate in KKR’s due diligence and the deal with KKR would have closed. See Plaintiff’s Memorandum of Law in Opposition to Defendant’s Motion for Summary Judgment (“Pl. Br.”) at 1, ECF No. 61. Specifically, Red Mountain argues that Brill made two fraudulent statements: (1) that he falsely told KKR he was not

conflicted by signing the engagement letter with KKR that contained a conflict provision; and (2) that he falsely told Ali Satvat, a banker at KKR, in August 2015 that he was not conflicted. Defendants now bring a motion for summary judgment on this remaining claim. Oral argument was held on January 24, 2023.1 Contrary to the characterization of this Court’s September 27, 2021 decision by plaintiff, this Court’s first opinion simply upheld this singular claim of fraud as a matter of pleading.2 See Mem. & Order at 24-26. However, with discovery

1 Brill filed a pre-motion letter seeking leave to file a motion for summary judgment on May 20, 2022. See ECF No. 49. On May 25, 2022, Red Mountain filed a pre-motion letter opposing Brill’s motion. See ECF No. 50. The Court held a pre-motion conference on June 13, 2022, in which it granted leave to file the motion for summary judgment. On July 25, 2022, Brill filed his motion for summary judgment. See ECF No. 57. On August 31, 2022, Red Mountain filed its opposition to Dr. Brill’s motion for summary judgment. See ECF No. 63. The motions were fully briefed on September 20, 2022. See ECF No. 67. 2 With concerning frequency, plaintiff misstates or overstates this Court’s ruling in its first opinion. Plaintiff’s counsel knows better than to endeavor to convert a ruling on a motion to dismiss that upholds the adequacy of a pleading with a determination on the merits. Even if portions of plaintiff’s brief were simply an exercise in hyperbole, it is, at a minimum, a fruitless one when addressing the author of the first opinion. -3- complete and a motion for summary judgment before the Court, plaintiff must actually support its claim of fraud. For the reasons stated below, the plaintiff has failed to do so and defendants’ motion for summary judgment is granted. BACKGROUND I. Factual Background3 Given the Court’s prior opinion, we assume familiarity with

the factual background of the case. As described therein, Brill was hired as a consultant by KKR to assist KKR in evaluating a potential financing of Red Mountain. KKR specifically hired Brill for his expertise and experience in gastroenterology and diagnostics. Def. 56.1 ¶ 24. On May 19, 2015, Brill signed an engagement letter with KKR, which contained a conflict provision. Def. 56.1 ¶ 28. The provision stated that during the engagement with KKR, Brill “shall not perform any services contemplated by or similar to those contemplated by this agreement to any third party concerning any investment in a Target Company.” Engagement Letter

3 The following facts are drawn primarily from the parties’ Rule 56.1 Statements and the documents submitted with each party’s briefings. Both parties submitted a Rule 56.1 Statement of Material Facts in support of their motions for summary judgment. See Def. Local Rule 56.1 Statement (“Def. 56.1”), ECF No. 58; Pl. Local Rule 56.1 Statement (“Pl. 56.1”), ECF No. 64. Both parties also submitted responses to each other’s 56.1 Statements. See Def. Response to Pl. Local 56.1 Statement, ECF No. 71; Pl. Response to Def. Local Rule 56.1 Statement, ECF No. 64 (“Pl. Reply 56.1”); Def. Rebuttal to Pl. Response to Def. Local Rule 56.1 Statement, ECF No. 69. Where the Court relies on facts drawn from any of the 56.1 Statements, it has done so because the evidence in the record supports the statements, no rule of evidence bars admission, and the opposing party has not disputed the facts or has not done so with citations to admissible evidence. -4- 4(c), ECF No. 50-15. Additionally, Brill had to inform KKR “if an engagement on behalf of another client of the Consultant would reasonably be expected to (i) give rise to a conflict of interest in respect of the Consultant’s services for KKR or (ii) result in the release of trade secrets or other proprietary or confidential information relating to the Project or KKR.” Engagement Letter 4(b), ECF No. 50-15. KKR sent Brill the draft engagement letter.

Def. 56.1 ¶ 25. Plaintiff does not argue that Brill drafted or edited the conflict provision of the engagement letter. Pl. Reply 56.1 ¶ 27. Moreover, the engagement letter was solely between KKR and Brill. Neither party suggests that the agreement was signed by or sent to Red Mountain. In fact, Red Mountain is not even identified by name in the engagement letter. Def. 56.1 ¶ 30; see Engagement Letter, ECF 50-15. In its prior opinion, the Court found that this agreement was for the sole benefit of KKR and that Red Mountain was not an intended beneficiary. Mem. & Order at 12-13. Brill was not the only expert hired by KKR as part of its due

diligence process. KKR hired multiple consultants and law firms to evaluate various aspects of Red Mountain’s business, including its regulatory compliance, intellectual property, accounting methods, and reimbursement practices. Def. 56.1 ¶ 19.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
William M. Gummo v. Village of Depew, New York
75 F.3d 98 (Second Circuit, 1996)
Wright v. Goord
554 F.3d 255 (Second Circuit, 2009)
Holcomb v. Iona College
521 F.3d 130 (Second Circuit, 2008)
Hicks v. Baines
593 F.3d 159 (Second Circuit, 2010)
Laugh Factory, Inc. v. Basciano
608 F. Supp. 2d 549 (S.D. New York, 2009)
Loreley v. Wells Fargo
13 F.4th 247 (Second Circuit, 2021)
Crigger v. Fahnestock & Co.
443 F.3d 230 (Second Circuit, 2006)
Gilman v. Marsh & McLennan Companies
826 F.3d 69 (Second Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Red Mountain Medical Holdings, Inc. v. Brill, M.D., Counsel Stack Legal Research, https://law.counselstack.com/opinion/red-mountain-medical-holdings-inc-v-brill-md-nysd-2023.